Our study demonstrating the association of CTLA-4 loss in CD4 T cells with shortened TTP seen in NDMM patients points to the possibility that blockade of CTLA-4 in MM may be an unfavorable strategy at diagnosis. This evidence concerns the gene CTLA4 and Miyoshi myopathy.